Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|September 5, 2006
Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitisL Verda, K Luo, D-A Kim, et al.
Annals of the Rheumatic Diseases|October 20, 2007
Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitisL Statkute, Y Oyama, W G Barr, et al.
Bone Marrow Transplantation|May 8, 2007
Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remissionY Loh, Y Oyama, L Statkute, et al.
Bone Marrow Transplantation|September 14, 2004
The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosisR K Burt, D Patel, J Thomas, et al.
Bone Marrow Transplantation|August 22, 2003
Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosusR K Burt, A Marmont, R Arnold, et al.
Bone Marrow Transplantation|May 19, 2009
Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemiaR K Burt, A Testori, Y Oyama, et al.
The Journal of Rheumatology. Supplement|October 20, 2001
Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritisS Z Pavletic, L W Klassen, R Pope, et al.
Journal of Clinical Immunology|May 8, 2000
Gene-marked autologous hematopoietic stem cell transplantation of autoimmune diseaseR K Burt, M Brenner, W Burns, et al.
Arthritis and Rheumatism|November 11, 1999
Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patientsR K Burt, C Georganas, J Schroeder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosisJ Das, J A Snowden, J Burman, et al.
Pageof 6